Skip to content
ppharmaranks
Menu

EMRELIS vs KRAZATI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. EMRELIS and KRAZATI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
New

Pharmacy pays

Type

RX
RX

Active ingredient

TELISOTUZUMAB VEDOTIN-TLLV
ADAGRASIB

Manufacturer

Dosage forms

Injectable
Tablet

Drug class

Boxed warning

None
None

Treats

Non-Small-Cell Lung Carcinoma
Non-Small-Cell Lung Carcinoma

Frequently asked questions

What is the difference between Emrelis and Krazati?

Emrelis contains Telisotuzumab Vedotin-Tllv, while Krazati contains Adagrasib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.